Source check: Source checked. Not independent scientific confirmation.
Finding: The source presents a proof discovered autonomously by GPT-6 Pro establishing an O_d(r^{-1/2}) zero-probability bound for degree-d multilinear polynomials with r disjoint degree-d monomials, improving the prior bound by removing a polylogarithmic factor and resolving the Nguyen–Vu conjecture. The key argument also proves a total-influence estimate for bounded-degree rational functions, resolving a recent conjecture of Kothari, Kovacs-Deak, Wang and Yang; these are one connected paper-level result, not separate entries.
Technology: OpenAI GPT-6 Pro
Family GPT-6: profile · models page
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- The author states that GPT-6 Pro autonomously discovered the proof and that the author claims no credit for the proof ideas; the author subsequently verified, digested and rewrote the argument.
- Test and result
- The source presents a proof discovered autonomously by GPT-6 Pro establishing an O_d(r^{-1/2}) zero-probability bound for degree-d multilinear polynomials with r disjoint degree-d monomials, improving the prior bound by removing a polylogarithmic factor and resolving the Nguyen–Vu conjecture.
- Limitation / still unknown
- This is an arXiv preprint. The author reports personally verifying and rewriting the proof; this review has not independently formalized it. Bound and related rational-function influence result are counted once because the paper derives them as a connected argument.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://arxiv.org/abs/2610.08708
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Source check: Source checked. Not independent scientific confirmation.
Finding: The paper gives a negative answer, already for q=2, to Talagrand’s question whether an operator’s Rademacher cotype is universally bounded by its Gaussian cotype and its (q,1)-summing norm. For every sufficiently large power-of-two dimension it constructs a Banach space and operator violating such a universal bound. The same construction also yields a negative answer to Kwapień’s decomposition problem.
Technology: ChatGPT GPT-5.6
Family GPT-5: profile · models page
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- The author states that the counterexample was discovered during discussions with GPT-5.6. The paper presents an explicit Walsh–Hadamard-based construction and proof; the author independently verified the arguments.
- Test and result
- The paper gives a negative answer, already for q=2, to Talagrand’s question whether an operator’s Rademacher cotype is universally bounded by its Gaussian cotype and its (q,1)-summing norm.
- Limitation / still unknown
- This is a single-author arXiv preprint, not a peer-reviewed publication. GPT-5.6 is credited with discovering the counterexample during discussions; the author says they independently verified all arguments. No Lean or other proof-assistant formalization is reported. The mathematical scope is the stated q=2 counterexample and its stated corollary, not a complete characterization of operator cotype.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://arxiv.org/abs/2609.19731
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Source check: Needs source check. Not independent scientific confirmation.
Finding: Celestolide inhibited CYP51 (IC50 133.28 ug/mL), showed antifungal activity and extended strawberry shelf life by more than a week in a gray-mold model. IC50 is weak in absolute terms; abstract only; field efficacy untested.
Technology: Neural relational inference and CorrSite2.0 (Gaussian network deep learning model)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Models identified the allosteric site used to select celestolide.
- Test and result
- Celestolide inhibited CYP51 (IC50 133.28 ug/mL), showed antifungal activity and extended strawberry shelf life by more than a week in a gray-mold model.
- Limitation / still unknown
- IC50 is weak in absolute terms; abstract only; field efficacy untested.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:%2210.1021/acs.jafc.5c05257%22&resultType=core&format=json
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 17 Nov 2026. Review scope: Abstract and metadata via Europe PMC; full text not read.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Source check: Needs source check. Not independent scientific confirmation.
Finding: 10,000 designed GLP-1RAs; 60 passed criteria; 62% in vitro success; two had half-lives about three times semaglutide and the best candidate outperformed semaglutide in diabetic and obesity mouse models. Preprint; mouse data only; head-to-head claims not independently checked; affiliations not read.
Technology: Deep-learning protein design plus functional screening
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- Deep-learning design generated peptide candidates before wet-lab screening.
- Test and result
- 10,000 designed GLP-1RAs; 60 passed criteria; 62% in vitro success; two had half-lives about three times semaglutide and the best candidate outperformed semaglutide in diabetic and obesity mouse models.
- Limitation / still unknown
- Preprint; mouse data only; head-to-head claims not independently checked; affiliations not read.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:%2210.1101/2025.03.26.645438%22&resultType=core&format=json
Needs source check · editorial details
The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Abstract and metadata via Europe PMC; full text not read.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.